Dyadic International, Inc. earnings per share and revenue
On 12 de nov. de 2025, DYAI reported earnings of -0.06 USD per share (EPS) for Q3 25, missing the estimate of -0.04 USD, resulting in a -35.75% surprise. Revenue reached 1.17 milhão, compared to an expected 1.12 milhão, with a 3.83% difference. The market reacted with a -3.87% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analistas forecast an EPS of -0.04 USD, with revenue projected to reach 1.37 milhão USD, implying an diminuir of -33.33% EPS, and aumentar of 17.63% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
22 de dez. de 2025 Para Q4 25
Estimativa
-$0.57
Real
-$0.73
Surpresa
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
19 de dez. de 2025 Para Q4 25
Estimativa
-$0.25
Real
-$0.19
Surpresa
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
23 de dez. de 2025 Para Q4 25
Estimativa
-$0.12
Real
-$0.06
Surpresa
+50.98%
FAQ
What were Dyadic International, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Dyadic International, Inc. reported EPS of -$0.06, missing estimates by -35.75%, and revenue of $1.17M, 3.83% above expectations.
How did the market react to Dyadic International, Inc.'s Q3 2025 earnings?
The stock price moved down -3.87%, changed from $0.94 before the earnings release to $0.91 the day after.
When is Dyadic International, Inc. expected to report next?
The next earning report is scheduled for 24 de mar. de 2026.
What are the forecasts for Dyadic International, Inc.'s next earnings report?
Based on 4
analistas, Dyadic International, Inc. is expected to report EPS of -$0.04 and revenue of $1.37M for Q4 2025.